default author photo

Nigel Hoggard

University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease

17 Mappin Street

Sheffield, S1 4DT

United Kingdom

SCHOLARLY PAPERS

1

DOWNLOADS

92

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Effect of Denosumab on Osteolytic Lesion Activity after Total Hip Arthroplasty: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Number of pages: 25 Posted: 15 Oct 2020
Mohit Mahatma, Raveen Jayasuriya, David Hughes, Nigel Hoggard, Simon Buckley, Andrew Gordon, Andrew Hamer, Wassim Tomouk, Robert Kerry, Richard Eastell and Jeremy Mark Wilkinson
University of Sheffield - Department of Oncology & Metabolism, Department of Oncology and Metabolism, University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, University of Sheffield - Department of Oncology & Metabolism and University of Sheffield - Department of Oncology & Metabolism
Downloads 92 (730,864)

Abstract:

Loading...

osteolysis, hip replacement, clinical trial, denosumab